METHOXYPROPYLAMINO CYCLOHEXENYLIDENE ETHOXYETHYLCYANOACETATE

UV filter allowed under conditions

Entry

Annex VI, No 32

Substance

2-ethoxyethyl (2Z)-2-cyano-2-[3-(3-methoxypropylamino) cyclohex-2-en-1-ylidene]acetate

Glossary names

Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate

CAS

1419401-88-9

EC

700-860-3

Maximum concentration

3%

Other conditions

- Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation - Do not use with nitrosating agents - Maximum nitrosamine content: 50 μg/kg - Keep in nitrite-free containers

Identity

CosIng identifier

89733

CAS (according to CosIng)

1419401-88-9

Declared functions

Light stabilizer, UV filter

United Kingdom (Great Britain)

• UV filter allowed under conditions (Annex VI)

Same entries as in the European Union. Conditions (concentrations, warnings) may differ: they are not compared here.

Switzerland

Regulation (EC) No 1223/2009 applies in Switzerland (Article 54 of the Ordinance on Foodstuffs and Utility Articles).

United States, federal rules

None of the integrated sections of the federal code (21 CFR 700.11 to 700.27 and 250.250) targets this name. The FDA does not publish a list of allowed ingredients.

South Korea

• Restricted: 메톡시프로필아미노사이클로헥세닐리덴에톡시에틸사이아노아세테이트(신설) (METHOXYPROPYLAMINO CYCLOHEXENYLIDENE ETHOXYETHYLCYANOACETATE)

  별표 2, 자외선 차단성분 (UV filters), entry 9, page 15. Limit: 3%. Conditions (source text, in Korean): 비고: ․흡입을 통해 사용자의 폐에 노출될 수 있는 제품에는 사용하지 말것 ․니트로 화제를 함유하고 있는 제품에는 사용 금지

Australia

• Active ingredient allowed in sunscreens: METHOXYPROPYLAMINO CYCLOHEXENYLIDENE ETHOXYETHYLCYANOACETATE

  Permissible Ingredients Determination (No. 3) 2026, sunscreen actives, entry 3287, page 75. Thresholds cited: must not be more than 3% | less than 0.000005%. Conditions (source text): Purpose: A | Until 20 June 2027, Methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate must only be used in a medicine where: | (a) BASF Australia Ltd (Client ID 13479) is the sponsor of the medicine (the primary sponsor); or | (b) another person is the sponsor of the medicine (the secondary sponsor) and the TGA has been notified that the secondary sponsor has been authorised by the primary sponsor to use the ingredient in the medicine. | Methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate must: | (a) only be used as an active ingredient in sunscreens in topical medicines for dermal application; and | (b) not be included in medicines that are intended for use on: | (i) the eye; or | (ii) broken skin. | The total concentration of methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate the medicine must not be more than 3%. | Methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate must not be used in combination with nitrosating substances. | The concentration of nitrosamine in the medicine must be less than 0.000005% or 50 ppb. | When used in primary sunscreen products, the following warning statements (or words to the same effect) must be included on the medicine label: | - (AVOID) ' Avoid prolonged exposure in the sun.'; | - (SUNPRO) ' Wear protective clothing - hats and eyewear when exposed to the sun.'.

Brazil

• Allowed under conditions: Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate

  RDC 600/2022, Anexo (allowed UV filters), entry 36, page 4. Limit: 3%. Conditions (source text, in Portuguese): OUTRAS LIMITAÇÕES E REQUERIMENTOS: a) Proibido em produtos cuja aplicação possa conduzir à exposição por inalação. b) Não usar com agentes nitrosantes. c) Teor máximo de nitrosaminas: 50 µg/kg. d)Embalar/conservar em recipientes livres de nitritos.